MANCHESTER, England — Even when C-reactive protein (CRP) levels are normal, patients with seropositive rheumatoid arthritis (RA) could still be experiencing significant disease that persists over time ...

The authors of this study used Mendelian randomization to assess whether C-reactive protein (CRP) is causative for coronary heart disease (CHD). In the absence of randomized studies directly ...

Lipoprotein(a) appears tied to the risk of major adverse cardiac events, MI, and peripheral artery disease in both primary and secondary prevention populations independent of baseline high-sensitivity ...

C-reactive protein is created by the liver in response to infections, tissue damage, chronic inflammatory states from conditions like autoimmune diseases, and metabolic disturbances like obesity and ...

In a real-world, prospective study, upadacitinib demonstrated great potential for the treatment of rheumatoid arthritis (RA) regardless of a patient’s baseline C-reactive protein (CRP) levels.

C-reactive protein (CRP) is produced by the liver in response to inflammation, signaling potential health issues. High-sensitivity CRP (hs-CRP) detects even minor inflammation, which can elevate heart ...

MILAN, Italy—Elevations in lipoprotein(a) are associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD) and aortic valve stenosis in patients with and without evidence of ...